Apr 27, 2010 by Brian Orelli, PhDBig Acquisition, Double-Digit Decline.Charles River Labs buys into China big time.
Apr 27, 2010 by Brian Orelli, PhDBoston Scientific's "Challenging" QuarterYeah, that's an understatement.
Apr 27, 2010 by Brian Orelli, PhDMake Money From 2020's Blockbuster DrugsSome trends for 2014 could point the way.
Apr 26, 2010 by Brian Orelli, PhDDendreon Watch 2010 (and Why You Should Ignore It)Media hype won't change the outcome.
Apr 23, 2010 by Brian Orelli, PhDA UnitedHealth Problem for MerckThere's more to drug sales than FDA approval.
Apr 23, 2010 by Brian Orelli, PhDA Fortress Called Zortress? Novartis Hopes YesNewly approved kidney transplant drug could do quite well for Novartis.
Apr 22, 2010 by Brian Orelli, PhDNo Drug Can Cure the Health-Care Reform InfectionReform takes a bite out of Amgen's solid quarter.
Apr 22, 2010 by Brian Orelli, PhDLow Standards Propel This StockMore bad news for Genzyme, but not its stock price.
Apr 22, 2010 by Brian Orelli, PhDAbbott's Stuck in a Double-Digit RutInvestors ignore its double-digit revenue growth.
Apr 21, 2010 by Brian Orelli, PhDYawn! Get Back to Me Next Quarter, J&JThere's more stagnant growth from the health-care giant.
Apr 21, 2010 by Brian Orelli, PhDKeep It Up and They'll Make You ChairmanNovartis' new leader is off to a productive start.
Apr 21, 2010 by Brian Orelli, PhDGilead's Pipeline Stumbles, Diversification FaltersIf its diversification plans had worked out, the bad quarter would have stung less.
Apr 20, 2010 by Brian Orelli, PhDDrug Sales Down! Should We Celebrate?Amylin tries to turns lemons into lemonade.
Apr 20, 2010 by Brian Orelli, PhDThis Company Looks Better Broken ApartElan is still trying to get rid of its drug technology business.
Apr 20, 2010 by Brian Orelli, PhDBiogen Says: We're Cheap!The biotech giant decides a buyback is its best use of cash.
Apr 19, 2010 by Brian Orelli, PhDThis Healthy Partnership Is a Perfect FitCIGNA and Humana fill each other's voids.
Apr 19, 2010 by Brian Orelli, PhDBad Quarter? Investors Still ShrugHealth-care reform hits Eli Lilly.
Apr 16, 2010 by Brian Orelli, PhDNext Stop for This Winner: World DominationOther countries follow U.S. in desire for these surgical machines.
Apr 16, 2010 by Brian Orelli, PhDIt'll Be a Blockbuster! High Fives All Around, Right?Sometimes clinical trial data isn't as bold as it seems.
